Position in NTLA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,691,982
+$1,408,795 QoQ
Shares Held
209,983
+47.1% QoQ
Ownership
0.150%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
19 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Derivatives in NTLA
reported options exposure · as of Dec 31, 2025CallValue
$119,567
CallShares
13,300
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Squarepoint Ops LLC holds $1,094,861,392 across 233 Biotechnology names. NTLA ranks #66 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
426,723 | $141,189,839 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
162,814 | $125,796,608 | |
| 3 | RPRX |
Royalty Pharma plc
|
1,349,516 | $64,736,282 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
695,276 | $52,208,274 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
556,324 | $41,312,620 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
52,884 | $27,683,187 | |
| 7 | ARQT |
Arcutis Biotherapeutics, Inc.
|
1,103,490 | $25,998,224 | |
| 8 | FOLD |
AMICUS THERAPEUTICS, INC.
|
1,705,829 | $24,666,287 |
All Filings in NTLA
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,691,982 | 209,983 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,283,187 | 142,735 | Shares | Defined | 2026-02-13 | |
| 2025-12-31 | $119,567 | 13,300 | Call | Defined | 2026-02-13 | |
| 2025-09-30 | $376,486 | 21,800 | Put | Defined | 2025-11-14 | |
| 2025-03-31 | $305,438 | 42,959 | Shares | Defined | 2025-08-27 | |
| 2024-12-31 | $1,182,522 | 101,417 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,312,816 | 63,884 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $297,206 | 13,280 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $6,761,297 | 245,776 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $306,028 | 10,037 | Shares | Defined | 2024-02-14 | |
| 2023-06-30 | $216,704 | 5,314 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $10,219,583 | 274,204 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,179,316 | 91,124 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $351,988 | 6,290 | Shares | Defined | 2022-11-14 | |
| 2022-03-31 | $4,073,662 | 56,057 | Shares | Defined | 2022-05-16 | |
| 2021-09-30 | $13,129,394 | 97,871 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,235,535 | 7,631 | Shares | Defined | 2021-08-16 | |
| 2020-12-31 | $2,442,505 | 44,899 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $1,455,653 | 73,222 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $1,132,389 | 53,872 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||